Search

Emily M. Le

Examiner (ID: 5908)

Most Active Art Unit
1648
Art Unit(s)
1648, 1734, 1793
Total Applications
433
Issued Applications
74
Pending Applications
96
Abandoned Applications
266

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6804624 [patent_doc_number] => 20030232018 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-18 [patent_title] => 'Stabilized formulations of adenovirus' [patent_app_type] => new [patent_app_number] => 10/342344 [patent_app_country] => US [patent_app_date] => 2003-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6376 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20030232018.pdf [firstpage_image] =>[orig_patent_app_number] => 10342344 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/342344
Stabilized formulations of adenovirus Jan 14, 2003 Abandoned
Array ( [id] => 662420 [patent_doc_number] => 07101676 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-09-05 [patent_title] => 'Methods for identifying compounds which inhibit binding of nucleocapsid 7 protein to HIV-1 RNA' [patent_app_type] => utility [patent_app_number] => 10/339217 [patent_app_country] => US [patent_app_date] => 2003-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 16163 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/101/07101676.pdf [firstpage_image] =>[orig_patent_app_number] => 10339217 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/339217
Methods for identifying compounds which inhibit binding of nucleocapsid 7 protein to HIV-1 RNA Jan 8, 2003 Issued
Array ( [id] => 6643613 [patent_doc_number] => 20030104067 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'Method of obtaining cellular immune responses from proteins' [patent_app_type] => new [patent_app_number] => 10/340034 [patent_app_country] => US [patent_app_date] => 2003-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11125 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20030104067.pdf [firstpage_image] =>[orig_patent_app_number] => 10340034 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/340034
Method of obtaining cellular immune responses from proteins Jan 7, 2003 Issued
Array ( [id] => 879340 [patent_doc_number] => 07354711 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-04-08 [patent_title] => 'Methods for inhibiting immunostimulatory DNA associated responses' [patent_app_type] => utility [patent_app_number] => 10/336635 [patent_app_country] => US [patent_app_date] => 2003-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 9910 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/354/07354711.pdf [firstpage_image] =>[orig_patent_app_number] => 10336635 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/336635
Methods for inhibiting immunostimulatory DNA associated responses Jan 2, 2003 Issued
Array ( [id] => 32601 [patent_doc_number] => 07785610 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-31 [patent_title] => 'Chimeric immunomodulatory compounds and methods of using the same—III' [patent_app_type] => utility [patent_app_number] => 10/328578 [patent_app_country] => US [patent_app_date] => 2002-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 26 [patent_no_of_words] => 66261 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/785/07785610.pdf [firstpage_image] =>[orig_patent_app_number] => 10328578 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/328578
Chimeric immunomodulatory compounds and methods of using the same—III Dec 22, 2002 Issued
Array ( [id] => 1071764 [patent_doc_number] => 06841346 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-01-11 [patent_title] => 'Methods for detecting bacteriophage MS2' [patent_app_type] => utility [patent_app_number] => 10/328226 [patent_app_country] => US [patent_app_date] => 2002-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7309 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 240 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/841/06841346.pdf [firstpage_image] =>[orig_patent_app_number] => 10328226 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/328226
Methods for detecting bacteriophage MS2 Dec 22, 2002 Issued
Array ( [id] => 1076716 [patent_doc_number] => 07615227 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-11-10 [patent_title] => 'Use of CpG oligodeoxynucleotides to induce angiogenesis' [patent_app_type] => utility [patent_app_number] => 10/499597 [patent_app_country] => US [patent_app_date] => 2002-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13027 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/615/07615227.pdf [firstpage_image] =>[orig_patent_app_number] => 10499597 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/499597
Use of CpG oligodeoxynucleotides to induce angiogenesis Dec 18, 2002 Issued
Array ( [id] => 6855701 [patent_doc_number] => 20030129202 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-10 [patent_title] => 'Mutated hepatitis b virus, its nucleic and protein constituents and uses thereof' [patent_app_type] => new [patent_app_number] => 10/169668 [patent_app_country] => US [patent_app_date] => 2002-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 17406 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 25 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20030129202.pdf [firstpage_image] =>[orig_patent_app_number] => 10169668 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/169668
Mutated hepatitis b virus, its nucleic and protein constituents and uses thereof Dec 15, 2002 Abandoned
Array ( [id] => 7394290 [patent_doc_number] => 20040038373 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-26 [patent_title] => 'Apoptotic EBV-transformed lymphocytes, a therapeutic agent for post-transplant lymphoproliferative disorder' [patent_app_type] => new [patent_app_number] => 10/314869 [patent_app_country] => US [patent_app_date] => 2002-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12768 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20040038373.pdf [firstpage_image] =>[orig_patent_app_number] => 10314869 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/314869
Apoptotic EBV-transformed lymphocytes, a therapeutic agent for post-transplant lymphoproliferative disorder Dec 8, 2002 Abandoned
Array ( [id] => 6865553 [patent_doc_number] => 20030191079 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-09 [patent_title] => 'Methods for treating and preventing infectious disease' [patent_app_type] => new [patent_app_number] => 10/306522 [patent_app_country] => US [patent_app_date] => 2002-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 26950 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20030191079.pdf [firstpage_image] =>[orig_patent_app_number] => 10306522 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/306522
Methods for treating and preventing infectious disease Nov 26, 2002 Issued
Array ( [id] => 6822116 [patent_doc_number] => 20030220277 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-27 [patent_title] => 'Methylation of plasmid vectors' [patent_app_type] => new [patent_app_number] => 10/291041 [patent_app_country] => US [patent_app_date] => 2002-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 15135 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20030220277.pdf [firstpage_image] =>[orig_patent_app_number] => 10291041 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/291041
Methylation of plasmid vectors Nov 7, 2002 Abandoned
Array ( [id] => 6678139 [patent_doc_number] => 20030228279 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-11 [patent_title] => 'Compositions and methods for viral delivery' [patent_app_type] => new [patent_app_number] => 10/283484 [patent_app_country] => US [patent_app_date] => 2002-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 25610 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0228/20030228279.pdf [firstpage_image] =>[orig_patent_app_number] => 10283484 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/283484
Compositions and methods for viral delivery Oct 28, 2002 Abandoned
Array ( [id] => 6649238 [patent_doc_number] => 20030104613 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'Method for producing adherent animal cells' [patent_app_type] => new [patent_app_number] => 10/148514 [patent_app_country] => US [patent_app_date] => 2002-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9446 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20030104613.pdf [firstpage_image] =>[orig_patent_app_number] => 10148514 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/148514
Method for producing adherent animal cells Oct 8, 2002 Abandoned
09/958713 Oligodeoxynucleotide and its use to induce an immune response Oct 6, 2002 Abandoned
Array ( [id] => 6740246 [patent_doc_number] => 20030157615 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-21 [patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same' [patent_app_type] => new [patent_app_number] => 10/145128 [patent_app_country] => US [patent_app_date] => 2002-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 238 [patent_figures_cnt] => 238 [patent_no_of_words] => 192233 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20030157615.pdf [firstpage_image] =>[orig_patent_app_number] => 10145128 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/145128
Secreted and transmembrane polypeptides and nucleic acids encoding the same Sep 30, 2002 Abandoned
10/129031 Recombinant therapeutic fusion proteins Sep 30, 2002 Abandoned
Array ( [id] => 4791713 [patent_doc_number] => 20080292686 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-27 [patent_title] => 'Vaccine' [patent_app_type] => utility [patent_app_number] => 10/491482 [patent_app_country] => US [patent_app_date] => 2002-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8140 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20080292686.pdf [firstpage_image] =>[orig_patent_app_number] => 10491482 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/491482
Vaccine Sep 29, 2002 Abandoned
Array ( [id] => 6705842 [patent_doc_number] => 20030152576 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-14 [patent_title] => 'Interaction between cd14 and hbv components' [patent_app_type] => new [patent_app_number] => 10/168032 [patent_app_country] => US [patent_app_date] => 2002-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 16490 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20030152576.pdf [firstpage_image] =>[orig_patent_app_number] => 10168032 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/168032
Interaction between cd14 and hbv components Sep 26, 2002 Abandoned
Array ( [id] => 7269451 [patent_doc_number] => 20040057969 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-25 [patent_title] => 'Compositions containing stabilized hepatitis antigen and methods of their use' [patent_app_type] => new [patent_app_number] => 10/251167 [patent_app_country] => US [patent_app_date] => 2002-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 20258 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0057/20040057969.pdf [firstpage_image] =>[orig_patent_app_number] => 10251167 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/251167
Compositions containing stabilized hepatitis antigen and methods of their use Sep 19, 2002 Abandoned
Array ( [id] => 6668880 [patent_doc_number] => 20030113864 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-19 [patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same' [patent_app_type] => new [patent_app_number] => 10/247058 [patent_app_country] => US [patent_app_date] => 2002-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 116 [patent_figures_cnt] => 116 [patent_no_of_words] => 45008 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20030113864.pdf [firstpage_image] =>[orig_patent_app_number] => 10247058 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/247058
Secreted and transmembrane polypeptides and nucleic acids encoding the same Sep 17, 2002 Abandoned
Menu